Search filters

Filters
Clear All

Phase

  • 1
  • 6
  • 12
  • 11
  • 2
  • 11
  • 3
  • 32
  • 82
  • 15
  • 3
  • 6
  • 73

Found 82 Uterine Fibroids trials

A listing of Uterine Fibroids medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years - 65 years
Accepts healthy volunteer
All genders
This study investigates the changes in the brain that occur in the first three years following a traumatic brain injury (TBI). The purpose of this study is to compare the rate of brain tissue loss in individuals with TBI to those without, using healthy participants as a control group.Participants in …
99 years or below
All genders
The primary objective is to assess the efficacy of mezagitamab compared with placebo in achieving durable platelet response in participants aged 18 years with chronic ITP. Durable platelet response through Week 24, defined as platelet count 50,000/uL on at least 4 of the 6 weekly platelet measurements between Week 19 …
Psilocybin: Motivation and Neurocognition in Individuals with Opioid Use Disorder
18 years - 60 years
All genders
This study is testing a substance called psilocybin to see how it affects the brain and thinking in people who are recovering from opioid addiction. Psilocybin is the main ingredient in “magic mushrooms.” In the body, it turns into a chemical called psilocin, which affects the brain's serotonin system. This …
8 years or above
All genders
Phase 3
Interventional
The purpose of this study is to investigate acanthamoeba keratitis. It evaluates whether including topical corticosteroids can improve vision in patients with this condition.This study focuses on evaluating the effectiveness of topical corticosteroids in treating acanthamoeba keratitis. It looks at how these medications might affect vision improvement.Who can participate: Participants …
18 years or above
All genders
Phase 2/3
Interventional
This study investigates genetic and familial dilated cardiomyopathy (DCM).The study evaluates the safety and effectiveness of an investigational medication compared to a placebo.Who can participate: Adults diagnosed with genetic or familial DCM, with stable symptoms and certain heart function criteria, may participate. Participants should not have DCM due to other …
6 years or above
All genders
Phase 4
Interventional
This study investigates pulmonary exacerbations in people with cystic fibrosis. The purpose of this study is to compare the effects of different antibiotic treatments given through a tube into a vein.The study evaluates the effectiveness and safety of using one type of antibiotic versus two types in treating pulmonary exacerbations. …
18 years or above
All genders
Phase 2
Interventional
The goal of this randomized clinical trial is to test the topical drug clascoterone in patients with pilonidal disease, which is a common, benign skin condition of the gluteal cleft. The main questions it aims to answer are:Does clascoterone improve the severity of pilonidal disease as scored by a physician?Does …
Accepts healthy volunteer
All genders
Observational
This study investigates myocardial glucose suppression in FDG PET/CT scans. The purpose of this study is to evaluate the effect of sodium-glucose cotransporter-1/2 inhibitors on glucose levels in the heart.The study evaluates the safety and effectiveness of combining a ketogenic diet with an investigational medication to enhance imaging results. Researchers …
18 years - 99 years
Female
Phase 1
To assess safety and tolerability, including dose-limiting toxicities (DLTs), maximum tolerated dose (MTD), or maximum administered dose (MAD; if no MTD is defined) of IMGN151 when administered intravenouslyTo determine recommended Phase 2 dose (RP2D) for IMGN151To characterize the pharmacokinetics (PK) and immunogenicity of IMGN151 -To assess ORR for IMGN151 using …
Autism Spectrum Program of Excellence
3 years - 99 years
All genders
The goal of the ASPE study is to investigate the genetic basis of autism spectrum disorder (ASD) and autism-related traits. Individuals 3 years old or older with a diagnosis (or suspected diagnosis) of autism spectrum disorder without intellectual disability, or with a deletion/duplication in the NRXN1 gene (2p16.3 deletion) and their family members, or …